
Basel Medical fell 97.8% from $14.76 to $0.32, behind the S&P 500's +9.7%. Its worst day was Nov 11 (−64.6%), and its low came Nov 16 at $0.30.
Nov 20, 2025 – Nov 19, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
Basel Medical shares rose 30.9%, while the S&P 500 fell 1.1%.
+30.9% · S&P 500 −1.1%
EPS of $0.01 was reported on $6.4M revenue.
+2.4% · S&P 500 −0.7%
Story events cover the past 12 months · Times ET
Basel Medical shares rose 32.2%, while the S&P 500 rose 0.4%.
+32.2% · S&P 500 +0.4%
Basel Medical shares rose 30.7%, while the S&P 500 rose 0.0%.
+30.7% · S&P 500 0.0%
Basel Medical shares rose 54.7%, while the S&P 500 fell 0.4%.
+54.7%, the year's best day · S&P 500 −0.4%
Basel Medical closed at its lowest level of the year, 98.0% below where the year started.
−35.7% · S&P 500 −1.9%
Where it ended: a close of $0.32 on Nov 19, 2026.
Nothing in the past 12 months.
All BMGL analyst actionsNothing in the past 12 months.
All BMGL dividend historyChart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for BMGL and SPY from Benzinga historical bars. Not investment advice.